Open Innovation Centered on a Cell Culture Center
First written in FY2018. 4 of 7 entries say "Restated". Latest entry: FY2026.
4 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「During the consolidated fiscal year, our cell culture center conducted not only culture evaluations for the KB2000 and MakCell® automated cell culture systems developed by our company, but also culture evaluations of separation containers for a bone marrow stem cell separation system targeted for launch. We also conducted joint research with the Institute of Medical Science, the University of Tokyo, and the School of Medicine at Yokohama City University.」
The company continues to use the cell culture center as a base for equipment evaluation, separation-container evaluation and joint research with universities. - FY2024AdvancedAnnual report
「July 2023 Established a joint research division within Osaka University for joint research with Osaka University.」
In addition to its industry-academia collaboration initiatives, including the cell culture center, the company established a joint research division within Osaka University. - FY2022RestatedAnnual report
「In the Life Science and Equipment Development Business, we will use the cell culture center as an open innovation center and actively promote joint research with research institutions and universities engaged in cutting-edge technology development, as well as business collaboration with companies.」
The company is continuing its policy of positioning the cell culture center as an open innovation center for joint research and corporate collaboration. - FY2020RestatedAnnual report
「We have also established our own cell culture center as an open innovation center and will work to actively promote joint research with research institutions and universities engaged in cutting-edge technology development, as well as business collaboration with companies.」
The cell culture center continues to be positioned as a center for joint research and business collaboration with universities, research institutions and companies. - FY2019RestatedAnnual report
「We are currently advancing joint research with Osaka University and Yokohama City University aimed at regenerative medicine, and are also conducting joint research with several companies aimed at developing new culture-related products.」
The cell culture center continues to be positioned as an open innovation center for joint research and new product development with universities and companies. - FY2019-Q1ReframedAnnual report
「Since its establishment in April 2016, we had managed expenses related to the cell culture center as part of the Life Science and Equipment Development Business. However, because the business has expanded and its importance in management control has increased, and because more R&D activities concerning the future do not belong to any existing segment, we changed the classification so that these expenses are included in corporate expenses under adjustments.」
The classification for managing cell culture center-related expenses was changed from the Life Science and Equipment Development Business to corporate expenses. The reasons were the expansion of the business and its increasing importance in management control, as well as the increase in future-oriented R&D outside the existing segments. - FY2018First statedAnnual report
「In April 2016, we established a cell culture center in Building B of the Industry-Academia Co-Creation Headquarters on Osaka University's Suita Campus. The center is intended to serve as an open innovation facility where we can promote joint research with universities and companies funded by competitive grants, conduct culture evaluation and develop culture technologies toward the launch of various bio-related equipment under development by our company, and actively pursue joint research on various culture technologies with other universities and companies.」
The cell culture center at Osaka University is positioned as an open innovation center for product evaluation, culture technology development, and joint research with universities and companies.